Table 1.
Number of Organisms Recovered From DFI Lesions During the Entire Study Period and During the Index Episode
| Pathogen | Pathogens During Entire Study Period (No. Episodes = 963), No. (%) |
Pathogens During Index Episode (No. Episodes = 648), No. (%) |
|
|---|---|---|---|
| Gram-positivea | 829 (86.0) | 579 (89.4) | |
| MRSA | 299 (31.4) | 224 (34.6) | |
| MSSA | 231 (23.6) | 160 (24.7) | |
| Streptococci | 265 (32.0) | 195 (30.1) | |
| Enterococci (vancomycin-susceptible) | 229 (23.8) | 166 (25.6) | |
| VRE | 68 (7.1) | 52 (8.0) | |
| Coagulase-negative Staphylococci | 129 (13.4) | 115 (17.8) | |
| Gram-negativea | 547 (56.8) | 375 (57.9) | |
| Enterobacteriaceae (ceftriaxone-susceptible) | 394 (40.9) | 275 (42.4) | |
| Enterobacteriaceae (ceftriaxone-resistant) | 74 (7.7) | 51 (7.9) | |
| CRE | 6 (0.6) | 6 (0.6) | |
| P. aeruginosa | 131 (13.6) | 94 (14.5) | |
| A. baumannii | 29 (3.0) | 22 (3.4) | |
| Other GNB | 74 (7.9) | 57 (8.8) | |
| Anaerobes | 197 (28.8) | 160 (24.7) | |
| Othersb | 124 (12.9) | 115 (17.7) | |
Abbreviations: CRE, carbapenem-resistant Enterobacteriaceae; GNB, Gram-negative bacilli; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; VRE, vancomycin-resistant Enterococci.
aThe percentages for each of the pathogens represent the proportion of pathogens of number of episodes. As some of the patients had more than 1 pathogen per episode, the sum of the percentages is >100%.
bOthers: Corynobacterium spp., Candida spp.